Triacetoxyperiodinane → 2-Cyclohexylmethyl-n-[1-(5-ethyl-[1,3,4]oxadiazole-2-carbonyl)-butyl]-4-morpholin-4-yl-4-oxo-butyramide
反応式
[CH:1]1([CH2:7][CH:8]([CH2:25][C:26]([N:28]2[CH2:33][CH2:32][O:31][CH2:30][CH2:29]2)=[O:27])[C:9]([NH:11][CH:12]([CH:16]([C:18]2[O:19][C:20]([CH2:23][CH3:24])=[N:21][N:22]=2)[OH:17])[CH2:13][CH2:14][CH3:15])=[O:10])[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.CC(OI1(OC(C)=O)(OC(C)=O)OC(=O)C2C=CC=CC1=2)=O.[O-]S([O-])=O.[Na+].[Na+].C([O-])(O)=O.[Na+]>>[CH:1]1([CH2:7][CH:8]([CH2:25][C:26]([N:28]2[CH2:33][CH2:32][O:31][CH2:30][CH2:29]2)=[O:27])[C:9]([NH:11][CH:12]([C:16]([C:18]2[O:19][C:20]([CH2:23][CH3:24])=[N:21][N:22]=2)=[O:17])[CH2:13][CH2:14][CH3:15])=[O:10])[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1参加物
反応物 3
生成物 1
実験手順
This amide was treated with Dess-Martin periodinane (239 mg, 0.48 mmol) at room temperature. After stiffing for 1 hour, 5 mls of saturated Na2SO3—NaHCO3 were added. After a further 0.5 hours, the reaction mixture was extracted with ethyl acetate, washed with brine, dried with MgSO4 and concentrated. The residue was purified with silica gel column chromatography to yield 65 mg of 2-cyclohexylmethyl-N-[1-(5-ethyl-[1,3,4]oxadiazole-2-carbonyl)-butyl]-4-morpholin-4-yl-4-oxo-butyramide; H1 NMR (DMSO-d): 8.6, 8.51(11H, dd, J=6.8 Hz, J=5.6 Hz, NH, diastereomeric), 4.98(−4.88 (1H, m), 3.6–3.25(8H, m), 3–2.9(2H, q, J=7.6 Hz), 2.9–2.75(1H, m), 2.5–2.4(1H, m), 2.3–2.1(1H, m), 1.9–1.7(2H, m), 1.7–1.4(7H, m), 1.4–1.2(2H, m), 1.28(3H, t), 1.2–1(6H, m), 0.88(3H, t); MS: 461.4(M−1), 463.4(M+1), 485.4(M+Na).
後処理
- waitAfter a further 0.5 hours
- extractionthe reaction mixture was extracted with ethyl acetate
- washwashed with brine
- dry with materialdried with MgSO4
- concentrationconcentrated
- customThe residue was purified with silica gel column chromatography
出典と根拠
- ORDレコード
- ord-60a92c94734740359d4c48d1a79e2d11
- 出典データセット
- uspto-grants-2006_06
- 特許番号
- US07064123B1
反応ノート
読み込み中…